Cardiovascular effects of noradrenaline microinjected into the dorsal periaqueductal gray area of unanaesthetized rats

The periaqueductal grey area (PAG) is a mesencephalic region that is involved in the modulation of cardiovascular changes associated with behavioural responses. Among the neurotransmitters present in the PAG, noradrenaline (NA) is also known to be involved in central nervous system cardiovascular regulation. In the present study we report the cardiovascular effects of the microinjection of NA into the dorsal portion of the PAG (dPAG) of unanaesthetized rats and the peripheral mechanism involved in their mediation. Injection of NA in the dPAG of unanaesthetized rats evoked a dose‐dependent pressor response accompanied by bradycardia. The magnitude of the pressor responses was higher at more rostral sites in the dPAG and decreased when NA was injected into the caudal portion of the dPAG. The responses to NA were markedly reduced in urethane‐anaesthetized rats. The pressor response was potentiated by i.v. pretreatment with the ganglion blocker pentolinium and blocked by i.v. pretreatment with the vasopressin antagonist dTyr(CH2)5(Me)AVP. The results suggest that activation of noradrenergic receptors within the dPAG can evoke pressor responses, which are mediated by acute vasopressin release.

[1]  G. L. Gebber,et al.  Defenselike patterns of spinal sympathetic outflow involving the 10-Hz and cardiac-related rhythms. , 2000, American journal of physiology. Regulatory, integrative and comparative physiology.

[2]  M. Behbehani Functional characteristics of the midbrain periaqueductal gray , 1995, Progress in Neurobiology.

[3]  P. Persson Modulation of cardiovascular control mechanisms and their interaction. , 1996, Physiological reviews.

[4]  L. Berrino,et al.  Role of vasopressin on excitatory amino acids mediated pressor responses in the periaqueductal gray area , 1998, Naunyn-Schmiedeberg's Archives of Pharmacology.

[5]  J. Paton,et al.  Excitatory convergence of periaqueductal gray and somatic afferents in the solitary tract nucleus: role for neurokinin 1 receptors. , 2005, American journal of physiology. Regulatory, integrative and comparative physiology.

[6]  L. Schenberg,et al.  Cardiovascular changes following acute and chronic chemical lesions of the dorsal periaqueductal gray in conscious rats. , 1999, Journal of the autonomic nervous system.

[7]  T. Lovick Inhibitory modulation of the cardiovascular defence response by the ventrolateral periaqueductal grey matter in rats , 2004, Experimental Brain Research.

[8]  L. Resstel,et al.  Medial prefrontal cortex modulation of the baroreflex parasympathetic component in the rat , 2004, Brain Research.

[9]  N. Schneiderman,et al.  Afferents to the central nucleus of the amygdala and functional subdivisions of the periaqueductal gray: neuroanatomical substrates for affective behavior , 2000, Brain Research.

[10]  R. Bandler,et al.  Excitation of neurones in a restricted portion of the midbrain periaqueductal grey elicits both behavioural and cardiovascular components of the defence reaction in the unanaesthetised decerebrate cat , 1987, Neuroscience Letters.

[11]  P. Larsen,et al.  Sympathetic nerve and cardiovascular responses to chemical activation of the midbrain defense region. , 2001, American journal of physiology. Regulatory, integrative and comparative physiology.

[12]  W P Wilson,et al.  Sensations evoked by stimulation in the midbrain of man. , 1969, Journal of neurosurgery.

[13]  F. Corrêa,et al.  CNS mediation of cardiovascular responses to the intracerebroventricular administration of catecholamines , 1982 .

[14]  L. Berrino,et al.  Interactive role of l-glutamate and vasopressin, at the level of the PAG area, for cardiovascular tone and stereotyped behaviour , 1992, Brain Research.

[15]  M. Palkovits,et al.  Regional concentrations of noradrenaline and dopamine in rat brain , 1976, Brain Research.

[16]  L. Berrino,et al.  Hypothalamic paraventricular nucleus involvement in the pressor response to N-methyl-d-aspartic acid in the periaqueductal grey matter , 2004, Naunyn-Schmiedeberg's Archives of Pharmacology.

[17]  L. Share Role of vasopressin in cardiovascular regulation. , 1988, Physiological reviews.

[18]  T. Lovick Ventrolateral medullary lesions block the antinociceptive and cardiovascular responses elicited by stimulating the dorsal periaqueductal grey matter in rats , 1985, Pain.

[19]  J. Antunes-Rodrigues,et al.  Mechanism of the CNS-mediated pressor response to intracerebroventricular injection of noradrenaline in unanaesthetized rats , 1985, Neuropharmacology.

[20]  Richard Bandler,et al.  Central circuits mediating patterned autonomic activity during active vs. passive emotional coping , 2000, Brain Research Bulletin.

[21]  G. Paxinos The Rat nervous system , 1985 .

[22]  Cowley Aw,et al.  Role of vasopressin in cardiovascular regulation. , 1983 .

[23]  M. X. Zarrow,et al.  Experimental Endocrinology: A Sourcebook of Basic Techniques , 1964 .

[24]  H. Gavras,et al.  α-Adrenoceptor agonists applied in the area of the nucleus tractus solitarii in the rat: effect of anesthesia on cardiovascular responses , 1985, Brain Research.

[25]  A. Cowley,et al.  Vasopressin and Arterial Pressure Regulation Special Lecture , 1988, Hypertension.

[26]  T. Day,et al.  A1 cell group mediates solitary nucleus excitation of supraoptic vasopressin cells. , 1989, The American journal of physiology.

[27]  Eszter Farkas,et al.  Periaqueductal gray matter input to cardiac-related sympathetic premotor neurons , 1998, Brain Research.

[28]  C. Saper,et al.  Organization of medullary adrenergic and noradrenergic projections to the periaqueductal gray matter in the rat , 1992, The Journal of comparative neurology.

[29]  R Bandler,et al.  Orbitomedial prefrontal cortical projections to distinct longitudinal columns of the periaqueductal gray in the rat , 2000, The Journal of comparative neurology.

[30]  R. F. Tavares,et al.  Mechanisms involved in the pressor response to noradrenaline injection into the cingulate cortex of unanesthetized rats , 2003, Neuropharmacology.